Detalhe da pesquisa
1.
Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumors.
Cancer
; 121(7): 1056-63, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25411085
2.
Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia.
Clin Lymphoma Myeloma Leuk
; 17(7): 450-456.e2, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28624543
3.
A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer.
Eur J Cancer
; 56: 1-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26798966
4.
Mitosis-targeting natural products for cancer prevention and therapy.
Curr Drug Targets
; 13(14): 1820-30, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23140292